YOLFTbeta
Cizzle Biotechnology Holdings PLC

Cizzle Biotechnology Holdings PLC

CIZ · LSE · Healthcare / Biotechnology

1.13GBX+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close1.13
Open1.13
Day Range1.12 – 1.20
52-Week Range1.20 – 3.90
Volume24.44K
Market Cap6.37M
P/E (TTM)0.00
Forward P/E0.00
EPS0.00
Dividend Yield0.00%
Beta-0.05
50-Day Avg1.62
200-Day Avg2.01

About

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood immunoassay test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Allan John Syms
  • Employees5
  • HeadquartersThe Shard, London, United Kingdom, SE1 9SG, UK
  • Websitehttps://cizzlebiotechnology.com

Leadership

  • Dr. Allan John SymsExecutive Chairman · b. 1956
  • Prof. Dawn CoverleyFounder, Chief Scientific Officer & Executive Director · b. 1965
  • Mr. Nigel R. LeeFinance Director & Executive Director · b. 1961

Financials

Income Statement

Currency: GBP2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue222.00K307.00K1.63M1.56M2.72M6.06M8.70M9.42M7.19M6.90M5.32M4.55M74.00K0000000
Growth (%)-+38.29%+430.29%-4.12%+74.25%+122.83%+43.56%+8.30%-23.72%-3.99%-22.92%-14.51%-98.37%-100.00%------
Cost of Revenue305.00K269.00K1.02M959.00K1.89M3.92M5.26M5.81M4.53M4.42M3.56M3.10M29.00K0000---
Gross Profit-83.00K38.00K605.00K602.00K832.00K2.15M3.44M3.61M2.66M2.48M1.76M1.45M45.00K0000---
Gross Margin-37.39%12.38%37.16%38.57%30.59%35.41%39.51%38.33%37.01%36.01%33.16%31.93%60.81%-------
Operating Expense1.29M2.17M2.54M1.02M1.73M3.24M4.24M4.30M4.20M5.48M3.15M3.48M1.78M21.71K229.00K-2.26M963.00K---
Operating Income-1.37M-2.13M-1.93M-416.00K-901.00K-1.09M-799.00K-693.00K-1.53M-2.99M-1.38M-2.03M-1.73M-21.71K-229.00K2.26M-963.00K-976.00K-878.00K-753.00K
Operating Margin-617.57%-693.81%-118.61%-26.65%-33.13%-18.02%-9.18%-7.35%-21.36%-43.34%-26.00%-44.56%-2341.89%-------
EBITDA-1.28M-1.90M-1.67M-334.00K-793.00K-783.00K-323.00K-175.00K-956.00K-291.00K-743.00K-1.15M-1.20M-21.71K-306.00K-851.00K-963.00K-976.00K-878.00K-753.00K
EBITDA Margin-578.83%-617.26%-102.40%-21.40%-29.15%-12.92%-3.71%-1.86%-13.30%-4.22%-13.97%-25.27%-1617.57%-------
Net Income-1.45M-1.86M-1.34M-369.00K-886.00K-1.02M-780.00K-651.00K-1.33M-2.77M-159.38-118.2-2.06M-21.71K-306.00K-3.92M-912.00K-1.72K-2.17K-691.00K
Net Income Margin-654.50%-607.49%-82.43%-23.64%-32.57%-16.89%-8.96%-6.91%-18.53%-40.10%-0.00%-0.00%-2779.73%-------
R&D497.00K545.00K590.00K246.00K325.00K408.00K---------161.00K280.00K214213234.00K
R&D as % of Total Revenue223.87%177.52%36.24%15.76%11.95%6.73%--------------
Interest Expense92.00K26.00K21.00K15.00K2.00K13.00K37.00K35.00K37.00K34.00K50.00K53.00K0006.21M----
Interest Expense % of Total Revenue41.44%8.47%1.29%0.96%0.07%0.21%0.43%0.37%0.51%0.49%0.94%1.17%0.00%-------

Balance Sheet

Currency: GBP2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets911.00K3.12M2.24M1.19M5.08M6.10M8.14M7.39M7.85M5.09M4.49M3.08M96.00K16.48K90.00K1.16M2.79M1.69M492.00K245.00K
Total Liabilities969.00K725.00K574.00K664.00K1.53M2.01M3.35M3.12M2.81M2.69M2.30M2.34M331.00K9.85K58.00K218.00K145.00K186.00K410.00K585.00K
Total Equity-136.00K2.40M1.67M521.00K3.54M4.08M4.79M4.27M5.05M2.40M2.19M741.00K-235.00K6.63K32.00K937.00K2.64M1.51M82.00K-340.00K
Cash219.00K2.00M641.00K32.00K1.89M748.00K1.95M603.00K1.14M197.00K225.00K44.00K4.00K12.82K84.00K875.00K478.00K144.00K365.00K116.00K
Total Debt228.00K164.00K106.00K-38.00K148.00K816.00K927.00K725.00K1.04M831.00K833.00K--10.00K-----
Net Debt9.00K-1.83M-535.00K-32.00K-1.85M-600.00K-1.14M324.00K-412.00K845.00K606.00K789.00K-4.00K-12.82K-83.99K-875.00K-478.00K-144.00K-365.00K-116.00K

Cash Flow

Currency: GBP2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.10M-2.10M-1.55M-150.00K-305.00K-1.51M-145.00K-678.00K-526.00K-570.00K186.00K-190.00K-513.00K-7.07K-294.00K-1.01M-872.00K-639.00K-358.00K-496.00K
Investing Cash Flow-33.00K-205.00K-278.00K-93.00K28.00K-845.00K-774.00K-783.00K-776.00K-809.00K-854.00K-418.00K225.00K-154.00K-154.00K-154.00K-120.00K---2.00K
Financing Cash Flow516.00K4.08M469.00K231.00K2.13M1.22M2.12M111.00K1.84M439.00K696.00K427.00K248.00K1.21M102.03M595.00K305.00K579.00K249.00K
Capital Expenditure161.00K484.00K374.00K85.00K112.00K756.00K774.00K783.00K776.00K809.00K907.00K467.00K176.00K00200.00K0002.00K
Free Cash Flow-1.26M-2.58M-1.92M-235.00K-417.00K-2.27M-919.00K-1.46M-1.30M-1.38M-721.00K-657.00K-689.00K-7.07K-294.00K-1.21M-872.00K-639.00K-358.00K-498.00K
Dividends Paid--------34.00K-----------
FCF to OCF114.68%123.10%124.14%156.67%136.72%150.07%633.79%215.49%247.53%241.93%-387.63%345.79%134.31%100.00%100.00%119.82%100.00%100.00%100.00%100.40%
Dividend Paid to FCF---------2.61%-----------

Earnings

Report DateSep 28, 2017Jun 29, 2018Sep 27, 2019Oct 13, 2020May 14, 2021Sep 30, 2021May 30, 2022Sep 28, 2022Apr 27, 2023Sep 30, 2024Apr 30, 2025Sep 30, 2025May 6, 2026
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual0.000.000.000.000.00-0.01-0.010.000.000.000.000.000.00
Surprise-------------
Timing-------------

Key Statistics & Ratios

Market Cap6.37M
Enterprise Value6.98M
Trailing P/E0.00
Forward P/E0.00
Price / Sales4026.30
Price / Book70.09
EPS0.00
Book Value-0.001
Revenue (TTM)25.00K
Gross Profit (TTM)25.00K
EBITDA-26.44K
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-433.59%
Return on Assets-203.40%
Shares Outstanding424.96M
Shares Float318.75M
Beta-0.05
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%